Blair Health raises $4.2M to close women’s specialist gap

Toronto healthtech Blair Health has closed a $4.24-million CAD pre-seed — its first institutional round — to scale software that lets nurse practitioners and family doctors deliver specialist-grade women’s care without the specialist wait.

The oversubscribed SAFE-and-convertible package was co-led by BDC’s Thrive Venture Fund, Montréal’s Accelia Capital and Ontario telehealth firm Ogaei, with Ontario Centre of Innovation’s Life Sciences Innovation Fund and angels. Total capital raised now sits at about $4.5 million. Proceeds fund product work, a bigger clinical and provider network, Canada and U.S. expansion, and a 12-person team.

Co-founded in December 2024 by CEO Madge Rumman and menopause subspecialist Dr. Lindsay Shirreff, Blair encodes specialist pathways — menopause and perimenopause first, then pelvic health and urology, plus nutrition and weight — into subscription telehealth with specialist oversight on hard cases. The company says women can wait up to two years for menopause care in the public system; its model aims for days, not months. It now has more than 2,300 users across every province and six U.S. states, with employer benefits already about half of H1 2026 revenue.

For Canadian households, the raise is another private bet on a public bottleneck: when wait lists and out-of-pocket specialist care become the default for midlife women’s health, capital follows software that routes scarce expertise through generalists — and pushes more of that cost onto employers and subscribers rather than the province.